GB0610395D0 - Novel imaging agents - Google Patents

Novel imaging agents

Info

Publication number
GB0610395D0
GB0610395D0 GBGB0610395.6A GB0610395A GB0610395D0 GB 0610395 D0 GB0610395 D0 GB 0610395D0 GB 0610395 A GB0610395 A GB 0610395A GB 0610395 D0 GB0610395 D0 GB 0610395D0
Authority
GB
United Kingdom
Prior art keywords
imaging agents
novel imaging
novel
agents
imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0610395.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Priority to GBGB0610395.6A priority Critical patent/GB0610395D0/en
Publication of GB0610395D0 publication Critical patent/GB0610395D0/en
Priority to US12/302,290 priority patent/US8304388B2/en
Priority to JP2009511581A priority patent/JP2009537624A/ja
Priority to CN2007800192052A priority patent/CN101454026B/zh
Priority to EP07732982A priority patent/EP2026844A2/en
Priority to BRPI0711937-2A priority patent/BRPI0711937A2/pt
Priority to RU2008146031/15A priority patent/RU2441668C2/ru
Priority to PCT/GB2007/001964 priority patent/WO2007138291A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GBGB0610395.6A 2006-05-25 2006-05-25 Novel imaging agents Ceased GB0610395D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB0610395.6A GB0610395D0 (en) 2006-05-25 2006-05-25 Novel imaging agents
US12/302,290 US8304388B2 (en) 2006-05-25 2007-05-25 Imaging agents
JP2009511581A JP2009537624A (ja) 2006-05-25 2007-05-25 新規造影剤
CN2007800192052A CN101454026B (zh) 2006-05-25 2007-05-25 成像剂
EP07732982A EP2026844A2 (en) 2006-05-25 2007-05-25 Novel imaging agents
BRPI0711937-2A BRPI0711937A2 (pt) 2006-05-25 2007-05-25 agente de formaÇço de imagem, precursor a preparaÇço do mesmo, composiÇço farmacÊutica, kit para a preparaÇço da mesma, mÉtodo para diagnose ou formaÇço de imagem in vivo em um indivÍduo de um condiÇço, uso de agente formaÇço de imagem, mÉtodo de monitoraÇço do efeito de tratamento de um corpo de animal ou de humano com uma froga
RU2008146031/15A RU2441668C2 (ru) 2006-05-25 2007-05-25 Новые визуализирующие агенты
PCT/GB2007/001964 WO2007138291A2 (en) 2006-05-25 2007-05-25 Novel imaging agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0610395.6A GB0610395D0 (en) 2006-05-25 2006-05-25 Novel imaging agents

Publications (1)

Publication Number Publication Date
GB0610395D0 true GB0610395D0 (en) 2006-07-05

Family

ID=36687722

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0610395.6A Ceased GB0610395D0 (en) 2006-05-25 2006-05-25 Novel imaging agents

Country Status (8)

Country Link
US (1) US8304388B2 (https=)
EP (1) EP2026844A2 (https=)
JP (1) JP2009537624A (https=)
CN (1) CN101454026B (https=)
BR (1) BRPI0711937A2 (https=)
GB (1) GB0610395D0 (https=)
RU (1) RU2441668C2 (https=)
WO (1) WO2007138291A2 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5604305B2 (ja) * 2007-12-13 2014-10-08 アンセルム（アンスチチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル） 線維症の非侵襲性の特異的イメージングのための、ポリペプチド、環状ポリペプチドおよびそれを含む医薬
HRP20190691T1 (hr) 2008-03-27 2019-07-12 Purdue Research Foundation Sintetički peptidoglikani koji vezuju kolagen, priprema, i postupci upotrebe
JP2010215572A (ja) * 2009-03-17 2010-09-30 Japan Health Science Foundation 歯髄炎診断マーカー及び歯髄炎診断システム
WO2011128931A1 (ja) * 2010-04-12 2011-10-20 財団法人ヒューマンサイエンス振興財団 歯髄炎診断マーカー及び歯髄炎診断システム
US9173919B2 (en) * 2011-02-16 2015-11-03 Purdue Research Foundation Collagen-targeted nanoparticles
EP3208278B1 (en) 2011-05-24 2018-10-31 Symic IP, LLC Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
WO2014055253A1 (en) * 2012-10-04 2014-04-10 The General Hospital Corporation Methods of synthesizing and using peg-like fluorochromes
EP4091624A1 (en) 2013-03-15 2022-11-23 Protagonist Therapeutics, Inc. Hepcidin analogues and uses thereof
WO2014144969A1 (en) 2013-03-15 2014-09-18 Purdue Research Foundation Extracellular matrix-binding synthetic peptidoglycans
US20140294902A1 (en) * 2013-04-02 2014-10-02 Protagonist Therapeutics, Inc. Novel a4b7 peptide antagonists
US20140294901A1 (en) * 2013-04-02 2014-10-02 Protagonist Therapeutics, Inc. Novel a4b7 peptide dimer antagonists
WO2015164822A1 (en) 2014-04-25 2015-10-29 Purdue Research Foundation Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
HRP20211448T1 (hr) 2014-05-16 2021-12-24 Protagonist Therapeutics, Inc. Alfa4beta7 integrin tioeter peptidni antagonisti
CN107206254B (zh) 2014-07-17 2021-08-24 领导医疗有限公司 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途
WO2016054411A1 (en) 2014-10-01 2016-04-07 Protagonist Therapeutics, Inc. NOVEL α4β7 PEPTIDE MONOMER AND DIMER ANTAGONISTS
US10301371B2 (en) 2014-10-01 2019-05-28 Protagonist Therapeutics, Inc. Cyclic monomer and dimer peptides having integrin antagonist activity
JP6942051B2 (ja) * 2015-01-30 2021-09-29 ユニヴァーシティー オブ ユタ リサーチ ファウンデーション 二量体のコラーゲンハイブリダイゼーションペプチドと使用方法
US10787490B2 (en) 2015-07-15 2020-09-29 Protaganist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
US20190002503A1 (en) 2015-12-30 2019-01-03 Protagonist Therapeutics, Inc. Analogues of hepcidin mimetics with improved in vivo half lives
EP3445402A4 (en) * 2016-04-21 2019-12-11 The Board Of Regents Of The University Of Texas System METHOD AND COMPOSITIONS FOR DETECTING ANEURYSMS
AU2018298224B2 (en) 2017-07-07 2024-08-15 Symic Ip, Llc Synthetic bioconjugates
WO2019044894A1 (ja) * 2017-08-31 2019-03-07 学校法人早稲田大学 コラーゲンへの結合活性を有する環状ペプチド
EP3681900A4 (en) 2017-09-11 2021-09-08 Protagonist Therapeutics, Inc. OPIOID AGONIST PEPTIDES AND THEIR USES
CA3089868A1 (en) 2018-02-08 2019-08-15 Protagonist Therapeutics, Inc. Conjugated hepcidin mimetics
WO2020014646A1 (en) 2018-07-12 2020-01-16 Protagonist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
JP7534382B2 (ja) 2019-07-10 2024-08-14 プロタゴニスト セラピューティクス， インコーポレイテッド インターロイキン－２３受容体のペプチド阻害剤及び炎症性疾患を治療するためのその使用
AU2021209086A1 (en) 2020-01-15 2022-08-04 Janssen Biotech, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
CA3167751A1 (en) 2020-01-15 2021-07-22 Janssen Biotech, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
JP7397239B2 (ja) 2020-11-20 2023-12-12 ヤンセン ファーマシューティカ エヌ．ベー． インターロイキン－２３受容体のペプチド阻害剤の組成物
EP4370146A4 (en) 2021-07-14 2025-05-21 Janssen Biotech, Inc. Lipidated peptide inhibitors of the interleukin-23 receptor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972890A (en) * 1988-05-02 1999-10-26 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging
WO1993021226A1 (en) 1992-04-10 1993-10-28 The General Hospital Corporation Cartilage matrix protein and methods for use
US7488792B2 (en) * 2002-08-28 2009-02-10 Burnham Institute For Medical Research Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
GB0326546D0 (en) * 2003-11-14 2003-12-17 Amersham Plc Inhibitor imaging agents
GB0327494D0 (en) 2003-11-26 2003-12-31 Amersham Plc Novel imaging agents
WO2005082941A1 (en) 2004-02-27 2005-09-09 The University Of Western Ontario Bone sialoprotein collagen-binding peptides
US7575738B2 (en) 2004-08-13 2009-08-18 General Electric Company Heat shock protein as a targeting agent for endothelium-specific in vivo transduction
GB0421308D0 (en) 2004-09-24 2004-10-27 Amersham Plc Enzyme inhibitor imaging agents
DE602005025911D1 (de) * 2004-11-22 2011-02-24 Ge Healthcare As Kontrastmittel für eine extrazelluläre matrix

Also Published As

Publication number Publication date
RU2008146031A (ru) 2010-06-27
WO2007138291A2 (en) 2007-12-06
US8304388B2 (en) 2012-11-06
US20090191123A1 (en) 2009-07-30
JP2009537624A (ja) 2009-10-29
BRPI0711937A2 (pt) 2012-07-24
RU2441668C2 (ru) 2012-02-10
WO2007138291A3 (en) 2008-05-29
EP2026844A2 (en) 2009-02-25
CN101454026A (zh) 2009-06-10
CN101454026B (zh) 2012-12-12

Similar Documents

Publication Publication Date Title
GB0610395D0 (en) Novel imaging agents
GB0519391D0 (en) Imaging agents
PT2371272T (pt) Imagiologia ocular
IL173715A0 (en) Substrate-guided imaging lens
EP2018048A4 (en) IMAGEUR SYSTEM
EP2046930A4 (en) FORMULATIONS BASED ON RHAMNOLIPIDS
IL202487A0 (en) Contrast agents
IL201794A0 (en) Optical imaging agents
GB0605780D0 (en) Formulations
GB0717365D0 (en) Imaging
GB0512770D0 (en) Imaging compounds
GB0502277D0 (en) Novel imaging agents
GB0616907D0 (en) Image construction
GB0610866D0 (en) Novel in vivo imaging compounds
GB0613287D0 (en) Dye imaging agents
GB2473774B (en) Improved fixing
GB0608960D0 (en) Imaging agent
GB0708092D0 (en) Imaging agents
GB0718887D0 (en) Imaging agents
GB0605931D0 (en) Endoscope
GB2442100B (en) Imaging material
ZA200909069B (en) Contrast agents
GB0818398D0 (en) Contrast agents
GB0716175D0 (en) Optical imaging agents
GB0821433D0 (en) Imaging Agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)